Industrial talks | 25/07/2023 | By Sudeep Soparkar | 1285
Industrial talks | 24/07/2023 | By Sudeep Soparkar | 418
Santen Agrees to Licensing Agreements and Asset Transfer for its Pharmaceutical Products in North America
Industrial talks | 20/07/2023 | By Sudeep Soparkar | 898
Endo Launches Bivalirudin Injection in Ready-to-Use Vials
Endo Launches Bivalirudin Injection in Ready-to-Use Vials
Industrial talks | 19/07/2023 | By Sudeep Soparkar | 753
Dr Reddys Laboratories Ltd signs for consumption of renewable energy
Dr Reddys Laboratories Ltd signs for consumption of renewable energy
Industrial talks | 17/07/2023 | By Sudeep Soparkar | 600
Himachal delegation visits Jawaharlal Nehru Pharma City (JNPC), Vizag
Himachal delegation visits Jawaharlal Nehru Pharma City (JNPC), Vizag
Industrial talks | 11/07/2023 | By Sudeep Soparkar | 1005
CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar
CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar
Industrial talks | 10/07/2023 | By Sudeep Soparkar | 878
Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect
Industrial talks | 10/07/2023 | By Sudeep Soparkar | 928
Industrial talks | 06/07/2023 | By Sudeep Soparkar | 735
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit
Industrial talks | 06/07/2023 | By Sudeep Soparkar | 722
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy